Howard Liang

Chief Financial Officer & Chief Strategy Officer at BeiGene Ltd.

Howard Liang

Howard Liang

Chief Financial Officer & Chief Strategy Officer at BeiGene Ltd.

Overview
Career Highlights

BeiGene Ltd.
BeiGene (Beijing) Co., Ltd.

RelSci Relationships

1972

Birthday

1964

Age

56

Relationships
RelSci Relationships are individuals Howard Liang likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Acting Head of Medicinal Chemistry at BeiGene Ltd.

Relationship likelihood: Strong

Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development at BeiGene Ltd.

Relationship likelihood: Strong

Senior Vice President, Global Head of Regulatory Affairs at BeiGene Ltd.

Relationship likelihood: Strong

Research Head of Chemistry at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Head of Molecular Sciences at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Head of Biologics at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Head of Discovery Biology at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Senior Director of Non-Clinical Development at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Paths to Howard Liang
Potential Connections via
Relationship Science
You
Howard Liang
Chief Financial Officer & Chief Strategy Officer at BeiGene Ltd.
Education
PhD in Biochemistry & Molecular Biology

UCE’s Office of Investments is responsible for managing the University's investment assets, which includes overseeing the endowment to ensure that it benefits both current and future generations of the University of Chicago. They oversee the broad investment strategy and provide input to the development of the strategic and tactical investment policies of the University & UCMC endowments, pension plans and self-insurance trust assets. Their strategy combines qualitative and quantitative analysis, seeking to achieve superior investment performance on a risk-adjusted basis.

BS in Chemistry

Peking University is a comprehensive and national key university. The campus, known as "Yan Yuan"(the garden of Yan), is situated at Haidian District in the western suburb of Beijing, with a total area of 2,743,532 square metres (or 274 hectares). It stands near to the Yuanmingyuan Garden and the Summer Palace. Peking University is proud of its outstanding faculty, including 53 members of the Chinese Academy of Sciences (CAS), 7 members of the Chinese Academy of Engineering (CAE), and 14 members of the Third World Academy of Sciences (TWAS). The university has effectively combined research on important scientific subjects with the training of personnel with a high level of specialized knowledge and professional skill as demanded by the country's socialist modernization. It strives not only for improvements in teaching and research work, but also for the promotion of interaction and mutual promotion among various disciplines. Thus Peking University has become a center for teaching and research and a university of a new type, embracing diverse branches of learning such as basic and applied sciences, social sciences and the humanities, and sciences of medicine, management, and education. Its aim is to rank among the world's best universities in the future

MBA

The University of Chicago Booth School of Business is a graduate business school located in Chicago, Illinois, at the University of Chicago. Formerly known as the University of Chicago Graduate School of Business, Chicago Booth is the second-oldest business school in the U.S., the first such school to offer an Executive MBA program, and the first to initiate a Ph.D. program in business. The school was renamed in 2008 following a $300 million endowment gift to the school by alumnus David G. Booth. The school has the third-largest endowment of any business school. The school's flagship campus is located in the Hyde Park neighborhood of Chicago on the main campus of the university. The school also maintains additional campuses in London and Asia (originally Singapore, but in July 2013 a move to Hong Kong was announced), as well as in downtown Chicago on the Magnificent Mile. In addition to conducting graduate business programs, the school conducts research in the fields of finance, economics, quantitative marketing research, and accounting. Chicago Booth is currently ranked first in the United States by Bloomberg Businessweek and first globally by the Economist.

Career History
Senior Scientist
Prior

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Analyst
2005 - 2015

Founded by Jeffrey Leerink in 1995, Leerink Swann LLC, formerly Leerink Swann & Co., is a full-service healthcare-focused investment banking firm that offers institutional sales, equity research, institutional trading, corporate finance and asset management services. The firm's investment banking activities include private placements, public offerings, private investment in public equity (PIPEs), registered direct offerings (RDOs and mergers & acquisitions.Leerink Swann's investment perspectives are driven by proprietary insights from MEDACorp., a network of over 35,000 physicians, researchers and healthcare professionals in North America, Europe, Asia and around the world with expertise in: clinical medicine, basic sciences, biomedical research, regulatory affairs, intellectual property, public health and policy, managed care, pharmacy management/pharmacy benefits management, healthcare administration, healthcare facilities, healthcare information technology, allied health services and healthcare consulting.Leerink Swann offers equity healthcare research coverage of the following areas: biotechnology, life science tools and diagnostics, pharmaceuticals, medical supplies and devices and healthcare services. The firm is also a market maker in over 350 NASDAQ equities.

Analyst
Prior

ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA.

Political Donations
$500
2010

Governor at Massachusetts Office of the Governor, Charles Baker

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Howard Liang. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Howard Liang's profile does not indicate a business or promotional relationship of any kind between RelSci and Howard Liang.